{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T08:03:28Z","timestamp":1725091408865},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>Medical records of 82 patients with acute lymphoblastic leukemia (ALL) who underwent hematopoietic cell transplantation (HCT) at our institution from 2005 to 2011 were reviewed. Forty-five patients were male (54.8%). The median age at HCT was 7.46 years (range, 0.98 to 14.31 y), the median time to HCT after diagnosis was 12.56 months. Ten patients were below the age of 1 year (12%). All patients were in complete remission at the time of HCT. In 83 transplants, 64 patients received HCT from human leukocyte antigen-identical\u2013related donors and 19 from other donors. Stem cell source was bone marrow in 65 (78%) and cord blood in 18 (22%). Five-year overall survival was 58.8% and event-free survival was 54.3%. The cumulative incidence of acute graft versus host disease was 4.8%\u00b12.3% and of chronic graft versus host disease was 8.9%\u00b13.2%. The median time to absolute neutrophil count and platelet recovery was 17 days (range, 12 to 43 d) and 28 days (range, 15 to 98 d), respectively. One patient acquired CMV infection after transplant. No one developed venoocclusive disease, hemorrhagic cystitis, or other complication. Patient\u2019s age at diagnosis, sex, donor\u2019s human leukocyte antigen status and sex, source of transplant and complete remission status at HCT did not affect overall survival and event-free survival. Our results show a favorable outcome to HCT for acute lymphoblastic leukemia patients comparable to published data, and no single factor was associated with superior outcome.<\/jats:p>","DOI":"10.1097\/mph.0000000000000679","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T16:07:56Z","timestamp":1480522076000},"page":"33-37","source":"Crossref","is-referenced-by-count":3,"title":["Factors Determining the Outcome of Hematopoietic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"],"prefix":"10.1097","volume":"39","author":[{"given":"Suleimman","family":"Al-Sweedan","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"},{"name":"Jordan University of Science & Technology, Irbid, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Al-Seraihy","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Al-Ahmari","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Al-Jefri","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viqaruddin","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafat","family":"Jafri","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khawar","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouhab","family":"Ayas","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","first-page":"652","article-title":"Acute lymphoblastic leukemia in children: treatment planning via minimal residual disease assessment","volume":"109","author":"Bartram","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"431","DOI":"10.7314\/APJCP.2015.16.2.431","article-title":"Patterns of childhood cancer incidence in Saudi Arabia (1999-2008)","volume":"16","author":"Al-Mutlaq","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"R3-20230918","first-page":"20","article-title":"Acute lymphoblastic leukemia in children: history of drug therapy management","volume":"4","author":"Bauters","year":"2014","journal-title":"J Pharm Belg"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jpc.12803","article-title":"Lessons from 50 years of curing childhood leukaemia","volume":"51","author":"Cole","year":"2015","journal-title":"J Paediatr Child Health"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"828145","DOI":"10.1155\/2015\/828145","article-title":"Identification of differentially expressed genes associated with prognosis of B acute lymphoblastic leukemia","volume":"2015","author":"Garza-Veloz","year":"2015","journal-title":"Dis Markers"},{"key":"R6-20230918","first-page":"4036","article-title":"Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children\u2019s cancer group","volume":"94","author":"Heerema","year":"1999","journal-title":"Blood"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1395::AID-CNCR25>3.0.CO;2-2","article-title":"Induction failure in acute lymphoblastic leukemia of childhood","volume":"85","author":"Silverman","year":"1999","journal-title":"Cancer"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<2030::AID-CNCR21>3.0.CO;2-Q","article-title":"Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children\u2019s Cancer Group","volume":"83","author":"Uckun","year":"1998","journal-title":"Cancer"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1182\/blood-2004-08-3312","article-title":"Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia","volume":"105","author":"Sanders","year":"2005","journal-title":"Blood"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/pbc.25333","article-title":"Hematopoietic stem cell transplantation in infants","volume":"62","author":"Gassas","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/bmt.2014.114","article-title":"New frontiers in pediatric Allo-SCT: novel approaches for children and adolescents with ALL","volume":"49","author":"Pulsipher","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12955-015-0240-6","article-title":"The impact of pediatric blood and marrow transplant on parents: introduction of the parent impact scale","volume":"13","author":"Heinze","year":"2015","journal-title":"Health Qual Life Outcomes"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/bmt.2015.43","article-title":"Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up","volume":"50","author":"Wilhelmsson","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbmt.2014.09.013","article-title":"Favorable outcome of hematopoietic stem cell transplantation using a targeted once-daily intravenous busulfan-fludarabine-etoposide regimen in pediatric and infant acute lymphoblastic leukemia patients","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.bbmt.2015.03.017","article-title":"The sequence of cyclophosphamide and myeloablative total body irradiation in hematopoietic cell transplantation for patients with acute leukemia","volume":"21","author":"Holter-Chakrabarty","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1182\/blood-2014-10-604702","article-title":"Comparison of transplantation with reduced and myeloablative conditioning for children with acute lymphoblastic leukemia","volume":"125","author":"Kato","year":"2015","journal-title":"Blood"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1200\/JCO.2014.58.9747","article-title":"Stem-cell transplantation in children with acute lymphoblastic leukemia: a prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial","volume":"33","author":"Peters","year":"2015","journal-title":"J Clin Oncol"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/leu.2015.59","article-title":"Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment","volume":"29","author":"Eckert","year":"2015","journal-title":"Leukemia"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/pbc.25353","article-title":"Hematopoietic stem cell transplantation following unsuccessful salvage treatment for relapsed acute lymphoblastic leukemia in children","volume":"62","author":"Inagaki","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R20-20230918","first-page":"445","article-title":"Acute leukemia child with ocular Kaposi\u2019s sarcoma after hematopoietic stem cell transplantation: a case report and literatures review","volume":"34","author":"Guo","year":"2013","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1111\/petr.12180","article-title":"Very late relapse of PTLD 10 yr after allogeneic HSCT and nine yr after stopping immunosuppressive therapy","volume":"18","author":"Helgestad","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1038\/bcj.2014.17","article-title":"The evolution of clinical trials for infant acute lymphoblastic leukemia","volume":"4","author":"Kotecha","year":"2014","journal-title":"Blood Cancer J"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3324\/haematol.2014.116707","article-title":"Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia","volume":"100","author":"Karawajew","year":"2015","journal-title":"Haematologica"},{"issue":"suppl 12","key":"R24-20230918","first-page":"13","article-title":"New developments in acute lymphoblastic leukemia","volume":"12","author":"Douer","year":"2014","journal-title":"Clin Adv Hematol Oncol"},{"key":"R25-20230918","first-page":"374","article-title":"Challenges of clinical trial design for targeted agents against pediatric leukemias","volume":"4","author":"Mussai","year":"2014","journal-title":"Front Oncology"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cct.2015.06.011","article-title":"Making strides and meeting challenges in pediatric allogeneic hematopoietic cell transplantation clinical trials in the United States: past, present and future","volume":"45(Part A)","author":"Satwani","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1200\/JCO.2000.18.9.1856","article-title":"Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcome","volume":"18","author":"Godder","year":"2000","journal-title":"J Clin Oncol"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/pbc.25602","article-title":"Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation","volume":"62","author":"Kato","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00277-014-2196-8","article-title":"Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia","volume":"94","author":"Boztug","year":"2015","journal-title":"Ann Hematol"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/bjh.12749","article-title":"Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol","volume":"165","author":"Gandemer","year":"2014","journal-title":"Br J Haematol"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00277-011-1285-1","article-title":"Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Zhao","year":"2012","journal-title":"Ann Hematol"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/bmt.2009.308","article-title":"Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL","volume":"45","author":"Giebel","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/pbc.23079","article-title":"Minimal residual disease detected prior to hematopoietic cell transplantation","volume":"57","author":"Foster","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbmt.2008.08.010","article-title":"Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen","volume":"14","author":"Kennedy-Nasser","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3346\/jkms.2009.24.5.904","article-title":"Unrelated hematopoietic stem cell transplantation for children with acute leukemia: experience at a single institution","volume":"24","author":"Lee","year":"2009","journal-title":"J Korean Med Sci"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00277-014-2213-y","article-title":"Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia","volume":"94","author":"Zheng","year":"2015","journal-title":"Ann Hematol"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/pbc.25245","article-title":"Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome","volume":"62","author":"Goto","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/petr.12285","article-title":"Scurvy: a new problem for patients with chronic GVHD involving mucous membranes; an easy problem to resolve","volume":"18","author":"Kletzel","year":"2014","journal-title":"Pediatr Transplant"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201701000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:03:56Z","timestamp":1695009836000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201701000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000679","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}